BlackRock
HPTX

BlackRock’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

BlackRock’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-319
Closed -$15K – 3350
2015
Q1 		$15K Hold
319
– – ﹤0.01% 2523
2014
Q4 		$8K Hold
319
– – ﹤0.01% 2928
2014
Q3 		$8K Hold
319
– – ﹤0.01% 2904
2014
Q2 		$8K Buy
319
+30
+10% +$771 ﹤0.01% 2972
2014
Q1 		$7K Buy
289
+58
+25% +$1.57K ﹤0.01% 2974
2013
Q4 		$5K Hold
231
– – ﹤0.01% 3077
2013
Q3 		$6K Hold
231
– – ﹤0.01% 2968
2013
Q2 		$5K Buy
+231
New +$5.06K ﹤0.01% 3060

BlackRock's HPTX Position: Q2 2015 in Review

BlackRock sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 319 shares — an estimated $15K sold.

BlackRock first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $15K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • BlackRock reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • BlackRock sold 319 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $15K.
  • BlackRock first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • BlackRock's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $15K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on BlackRock's 13F filing for Q2 2015, filed 7 Aug 2015.